Intended Use

The ACUSON Redwood ultrasound imaging system is intended to provide images or signals from inside the body in clinical settings for fetal, abdominal, pediatric, small parts, OB/GYN, cardiac, pelvic, cephalic, vascular, musculoskeletal, transcranial, and peripheral vascular applications, including a measurement tool (UDFF) for aiding hepatic steatosis management.

Technology

The system is a mobile, software-controlled ultrasound device capable of multiple imaging modes including 2D, M-mode, Color Doppler, Pulsed and Continuous Wave Doppler, Harmonic imaging, and volume imaging. It uses proprietary software to acquire and display harmonic ultrasound echo data and supports measurement features like Auto IMT and UDFF. It operates with various transducers and integrates safety features based on standardized medical device safety and performance standards.

Performance

The device underwent acoustic output, biocompatibility, and safety testing per relevant standards. Clinical validation included two studies evaluating the UDFF measurement tool demonstrating excellent reliability, strong correlation with predicate devices, and good agreement with MRI-PDFF reference, without requiring additional clinical studies due to technological equivalence with predicate devices.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    10/18/2024

    28 days
  • 2

    FDA Approval

    11/15/2024

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.